Arash Sadri

Arash Sadri

Auto-generated profile, based on publicly available information

Arash Sadri

Lyceum Scientific Charity Tehran Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASArash Sadri
Arash Sadri

18 June 2020 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
FYFarzaneh Yousefzadeh
Farzaneh Yousefzadeh
ESErfan Sahebolzamani
Erfan Sahebolzamani
ASArash Sadri
Arash Sadri
AMAmirhosein Mortezaei
Amirhosein Mortezaei
AAAli Aqamolaei
Ali Aqamolaei
SAShahin Akhondzadeh
Shahin Akhondzadeh
On the basis of numerous previous studies, the serotonergic system plays a role in the pathogenesis of obsessive-compulsive disorder (OCD) and effective agents in this pathway, such as 5-hydroxytryptophan, can potentially contribute to treatment of patients with this disorder. Evaluating the efficacy of 5-hydroxytryptophan in treating OCD was the aim of the present randomized, double-blind, placebo-controlled 12-week trial. In a 12-week, randomized double-blind study, 60 patients with a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnosis of moderate to severe OCD and a Yale–Brown Obsessive Compulsive Scale (Y-BOCS) score of >21 were randomly assigned to receive either fluoxetine plus placebo or fluoxetine plus 5-hydroxytryptophan (100 mg twice daily). All patients, regardless of their treatment group, received fluoxetine at 20 mg/day for the initial 4 weeks of the study followed by 60 mg/day of fluoxetine for the rest of the trial course. Symptoms were assessed using the Y-BOCS at baseline and weeks 4, 8 and 12. General linear model repeated measure showed significant effects for time × treatment interaction on total Y-BOCS (F = 12.07, df = 2.29, P-value <0.001), obsession (F = 8.25, df = 1.91, P-value = 0.001) and compulsion subscale scores (F = 6.64, df = 2.01, P-value = 0.002). 5-Hydroxytryptophan augmentation therapy demonstrated higher partial and complete treatment response rate (P = 0.032 and P = 0.001, respectively) according to the Y-BOCS total scores. The results of this study confirm that 5-hydroxytryptophan may be effective as an augmentative agent in treatment of moderate-to-severe OCD.

29 March 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NANima Aramipour
Nima Aramipour
MGMaryam Gholami
Maryam Gholami
MSMohammad Saber
Mohammad Saber
SGSoroor Jafar Gandomi
Soroor Jafar Gandomi
NLNaser-Aldin Lashgari
Naser-Aldin Lashgari
OSOmid Sabzevari
Omid Sabzevari

16 November 2022 in Dermatologic Therapy
Verified
Journal Article
Open access
AAAzin Ayatollahi
Azin Ayatollahi
NANima Aramipour
Nima Aramipour
ASArash Sadri
Arash Sadri
AFAlireza Firooz
Alireza Firooz
RRReza M. Robati
Reza M. Robati
MSMohammad Saber
Mohammad Saber
Despite the considerably high prevalence of cutaneous warts, no optimally effective and safe treatment is available. Leaves of date palm ( Phoenix dactylifera L.; Arecaceae) have long been used in Iran's folk medicine as a remedy for warts. To assess the state‐of‐the‐art evidence on using P. dactylifera L. for warts, we conducted a systematic review using CINAHL (via EBSCO), Embase, Medline (via PubMed), ProQuest, Scopus, and Web of Science. We conducted an open‐label uncontrolled pilot clinical study to evaluate the efficacy and safety of a proprietary topical date palm leaf‐based ointment for the treatment of various types of nongenital warts. This study consisted of an 8‐week treatment phase and a 4‐week follow‐up phase. The assessed outcomes included complete clearance, patient satisfaction (on Likert scale), and the occurrence of any adverse effect. The systematic review demonstrated that the effects of date palm on warts have not been scientifically studied. Thirty patients entered the study with a mean age of 29.5 years (SD = 14.04); among which 17 were female and 13 were male. The patients presented diverse types of warts: verruca vulgaris 15 (50%), plantar 9 (30%), plane 2 (7%), periungual 2 (7%), and warts at multiple sites 2 (7%). In this trial, 19 patients (63.3%) experienced complete clearance and 5 patients (16.6%) experienced partial clearance. Eight patients (26.67%) dropped out during the study. 21 (70%) patients were very satisfied (score on Likert scale = 5) while 1 (3.3%) patient with partial clearance was somewhat satisfied (score on Likert scale = 4). No adverse effect was observed. The results of this pilot study indicate that the date palm leaf‐based ointment is a promising treatment whose efficacy and safety should be further investigated in a randomized controlled clinical trial.

6 April 2022 in OSF Preprints
Verified
Preprint
Open access
ASArash Sadri
Arash Sadri
Target-based drug discovery has dominated drug discovery for decades. Despite criticisms and evidence against its reductionism, there lacks a comprehensive assessment of its real-world efficiency. Here, its inefficiency is shown by a massive corpus of evidence from a manual and systematic review of about 32000 articles and patents dating back to 150 years ago. Discovery origins of all approved drugs showed, despite decades of dominance, only 9.4% are small molecules discovered by “target-based” assays. Analysis of therapeutic mechanisms showed that the therapeutic effects of even this minimal share are not reducible to their “targets” and are indebted to numerous off-targets unconsciously incorporated by phenotypic observations. While highlighting reductionist target-based drug discovery as a main reason for drug discovery’s low productivity, the data suggests that an evidence-based approach to increasing efficiency is to maximally prioritize in selecting and optimizing molecules, higher-level phenotypic observations that are closer to the sought therapeutic effect.

16 October 2024 in Psychiatry and Clinical Neurosciences Reports
Verified
Journal Article
Open access
FRFatemeh Rashidi
Fatemeh Rashidi
MPMohammadamin Parsaei
Mohammadamin Parsaei
IKIman Kiani
Iman Kiani
ASArash Sadri
Arash Sadri
MAMohammad Hadi Aarabi
Mohammad Hadi Aarabi
HMHossein Sanjari Moghaddam
Hossein Sanjari Moghaddam
Aim: To explore white matter (WM) tracts linked to impulsivity using the diffusion magnetic resonance imaging (DMRI) connectometry method.Methods: We analyzed 218 healthy participants from the Leipzig Study for Mind‐Body‐Emotion Interactions database. Impulsivity correlations with DMRI‐derived WM changes were assessed using Urgency‐Premeditation‐Perseverance‐Sensation (UPPS) Impulsive Behavior Scale subscales: lack of perseverance (PE), lack of premeditation (PM), sensation seeking (SS), and negative urgency. DMRI data were processed using connectometry, adjusting for sex and age, to examine WM tract integrity via quantitative anisotropy (QA). Also, two additional interaction analyses were conducted to separately examine the interaction effect between WM QA, and sex and age in predicting impulsive behavior scores. The significance level in our statistical analyses was set at a false discovery rate (FDR) below 0.05.Results: QA in the bilateral cerebellum and middle cerebellar peduncle showed a negative association with PE and PM severity (FDR = 0.0004). QA in the middle cerebellar peduncle, corpus callosum body, and forceps major demonstrated a positive association with SS (FDR = 0.0001). Conversely, QA in forceps minor had a positive association with PM (FDR = 0.004), and QA in forceps minor and bilateral cingulum showed a positive association with SS (FDR = 0.0005). Age and sex had no significant effects on the association between WM QA and UPPS subscale scores.Conclusion: Impulsivity is linked to distinct WM integrity changes in various tracts, including the corpus callosum, cerebellum, and cingulum, offering insights into the pathophysiology of impulsivity and guiding future research.